Roopa Sethi Selected Research

Buprenorphine (Subutex)

1/2024	The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient Setting.
1/2023	The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature.
12/2022	Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder.
1/2022	Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days after Administration.
1/2022	Role of Buprenorphine in an Adolescent with Opioid Abuse.
11/2021	Successful Sublingual Buprenorphine Induction and Maintenance for Opioid Use Disorder in a Patient With Reduced Salivary Production, Aspiration Pneumonia, and an Enteral Tube.
1/2021	Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".
9/2020	Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic Instability.
1/2020	Enhanced Metabolism of Buprenorphine in a Man Prescribed Prednisone for Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roopa Sethi Research Topics

Disease

14	Opioid-Related Disorders (Opiate Addiction) 01/2024 - 01/2020
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2024 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 10/2023 - 01/2023
2	Bradycardia 10/2023 - 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2024
1	Opiate Overdose 11/2023
1	Hyperglycemia 10/2023
1	Hypertension (High Blood Pressure) 10/2023
1	Injection Site Reaction 01/2022
1	Aspiration Pneumonia 11/2021
1	Pain (Aches) 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Alcoholism (Alcohol Abuse) 05/2019
1	Delirium 01/2013
1	Paraphilic Disorders (Paraphilia) 01/2013
1	Hypothermia 01/2012
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2012
1	Schizophrenia (Dementia Praecox) 01/2012

Drug/Important Bio-Agent (IBA)

9	Buprenorphine (Subutex)FDA LinkGeneric 01/2024 - 01/2020
2	Naloxone Drug Combination Buprenorphine FDA Link 01/2024 - 07/2022
2	Opioid Analgesics (Opioids)IBA 01/2024 - 01/2020
2	Xylazine (Xylazin)IBA 10/2023 - 01/2023
2	Methadone (Dolophine)FDA LinkGeneric 01/2023 - 12/2022
1	tianeptine (Stablon)IBA 01/2024
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2023
1	Oxycodone (Oxycontin)FDA LinkGeneric 11/2023
1	Controlled SubstancesIBA 01/2023
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Naltrexone (ReVia)FDA LinkGeneric 05/2019
1	SaltsIBA 01/2013
1	Antipsychotic Agents (Antipsychotics)IBA 01/2013
1	NyquilIBA 01/2012
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2012
1	Sertraline (Zoloft)FDA LinkGeneric 01/2012
1	ziprasidone (Geodon)FDA Link 01/2012

Therapy/Procedure

1	Therapeutics 01/2024
1	Transdermal Patch 01/2024
1	Self Medication 01/2020